NCT00517348View on ClinicalTrials.gov

Study Evaluating IMA-026 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Healthy
Interventions
BIOLOGICAL

IMA-026

SC and IV ascending single doses from lyophilized dosage form 0.3, 1, 2, 4 mg/kg SC and 3 mg/kg IV

Trial Locations (1)

78217

San Antonio

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00517348 - Study Evaluating IMA-026 in Healthy Subjects | Biotech Hunter | Biotech Hunter